Efficacy of once daily tobramycin for acute pulmonary exacerbations of cystic fibrosis (CF) - A microbiological perspective

被引：0
|
作者：
Al-Ansari, N
McKeon, D
Parmar, J
Gunn, E
Foweraker, J
Bilton, D
机构：
[1] Papworth Hosp, Dept Microbiol, Cambridge CB3 8RE, England
[2] Papworth Hosp, Adult Cyst Fibrosis Ctr, Cambridge CB3 8RE, England
来源：
THORAX | 2001年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P135
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [41] EFFECT OF AZITHROMYCIN ON THE RESPONSE TO PULMONARY EXACERBATIONS TREATED WITH INTRAVENOUS TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
    Klingel, M.
    Ratjen, F.
    Stanojevic, S.
    Tullis, D. E.
    Nichols, D. P.
    Waters, V. J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S381 - S381
  • [42] Nebulized Tobramycin in the Treatment of Adult CF Pulmonary Exacerbations
    Al-Aloul, Mohamed
    Nazareth, Dilip
    Walshaw, Martin
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : 299 - 305
  • [43] Pulmonary exacerbations in cystic fibrosis
    Rabin, HR
    Butler, SM
    Wohl, MEB
    Geller, DE
    Colin, AA
    Schidlow, DV
    Johnson, CA
    Konstan, MW
    Regelmann, WE
    PEDIATRIC PULMONOLOGY, 2004, 37 (05) : 400 - 406
  • [44] Pulmonary exacerbations in cystic fibrosis
    Stenbit, Antine E.
    Flume, Patrick A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (06) : 442 - 447
  • [45] Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis
    Klingel, Michelle
    Stanojevic, Sanja
    Tullis, Elizabeth
    Ratjen, Felix
    Waters, Valerie
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (07) : 861 - 867
  • [46] TOBRAMYCIN AND TICARCILLIN THERAPY FOR EXACERBATIONS OF PULMONARY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS
    PARRY, MF
    NEU, HC
    JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S194 - S199
  • [47] Cystic fibrosis pulmonary exacerbations
    Ferkol, T
    Rosenfeld, M
    Milla, CE
    JOURNAL OF PEDIATRICS, 2006, 148 (02): : 259 - 264
  • [48] Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt, Olaf
    Lehmann, Christine
    Madabushi, Rajanikanth
    Kumar, Vipul
    Derendorf, Hartmut
    Welte, Tobias
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 822 - 829
  • [49] Sequential ciprofloxacin therapy in pediatric cystic fibrosis: Comparative study vs ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations
    Church, DA
    Kanga, JF
    Kuhn, RJ
    Rubio, TT
    Spohn, WA
    Stevens, JC
    Painter, BG
    Thurberg, BE
    Haverstock, DC
    Perroncel, RY
    Echols, RM
    Chiaro, JJ
    Farrell, MM
    Hoppe, M
    Stutman, HR
    Nussbaum, E
    Chin, T
    Zaleska, M
    Guill, M
    Hudson, VL
    Turcios, NL
    Heenehan, M
    Schnaph, B
    Kirley, S
    Buffington, D
    Garvin, J
    Stokes, D
    Smith, B
    Diakin, D
    Herbert, L
    Farrington, E
    Blagburn, M
    Hsu, J
    Rao, B
    Abdulhamid, I
    Lauzen, S
    Saba, M
    Stewart, S
    Craigmyle, LJ
    Morin, M
    McCarty, J
    Caplan, DB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (01) : 97 - 105
  • [50] EFFECT OF PROTON PUMP INHIBITORS ON CYSTIC FIBROSIS (CF) PULMONARY EXACERBATIONS IN ADULTS
    DiMango, E.
    Walker, P.
    Keating, C.
    Berdella, M.
    Robinson, B.
    Langfelder-Schwind, E.
    Levy, D.
    Liu, X.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 353 - 353
12345